CME Group Inc
NASDAQ:CME

Watchlist Manager
CME Group Inc Logo
CME Group Inc
NASDAQ:CME
Watchlist
Price: 273.55 USD 0.88% Market Closed
Market Cap: 98.6B USD

Intrinsic Value

The intrinsic value of one CME stock under the Base Case scenario is 156.61 USD. Compared to the current market price of 273.55 USD, CME Group Inc is Overvalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CME Intrinsic Value
156.61 USD
Overvaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CME Group Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CME?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CME valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CME Group Inc.

Explain Valuation
Compare CME to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

CME Group’s reliance on high trading volumes leaves it vulnerable to declining market volatility or prolonged stretches of muted economic activity, which could significantly reduce transaction-based revenue streams and compress margins.

Intensifying competition from rival exchanges and over-the-counter platforms offering similar or more flexible products could erode CME’s market share, leading to reduced pricing power and lower trading fees over time.

Potential regulatory changes that mandate alternative clearing arrangements or limit CME Group’s cross-margining advantages could undermine its clearing monopoly, increasing compliance costs and weakening its competitive moat.

Bull Theses

CME Group’s diversified product mix—ranging from interest rate futures to agricultural and energy contracts—positions the exchange to capitalize on heightened hedging demand across multiple asset classes during market volatility.

The firm’s robust technology infrastructure and vertical integration of clearing services provide cost efficiencies and heighten customer stickiness, reinforcing its ability to sustain high operating margins and generate resilient cash flows.

Strategic partnerships and international expansion efforts, particularly in Asia, open new channels for growth as more global market participants seek sophisticated hedging instruments and derivative products.

Show More Less
How do you feel about CME?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CME Group Inc

Current Assets 152.8B
Cash & Short-Term Investments 2.6B
Receivables 642.9m
Other Current Assets 149.6B
Non-Current Assets 34.3B
PP&E 355.2m
Intangibles 30.4B
Other Non-Current Assets 3.6B
Current Liabilities 149.6B
Accounts Payable 74.9m
Other Current Liabilities 149.5B
Non-Current Liabilities 9.4B
Long-Term Debt 3.4B
Other Non-Current Liabilities 5.9B
Efficiency

Free Cash Flow Analysis
CME Group Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CME Group Inc

Revenue
11.3B USD
Operating Expenses
-2.2B USD
Operating Income
9.1B USD
Other Expenses
-5.3B USD
Net Income
3.7B USD
Fundamental Scores

CME Profitability Score
Profitability Due Diligence

CME Group Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Strong 3Y Average Operating Margin
Exceptional Net Margin
Strong 3Y Average Net Margin
55/100
Profitability
Score

CME Group Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

CME Solvency Score
Solvency Due Diligence

CME Group Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Positive Net Debt
Long-Term Solvency
61/100
Solvency
Score

CME Group Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CME Price Targets Summary
CME Group Inc

Wall Street analysts forecast CME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CME is 289.08 USD with a low forecast of 203.01 USD and a high forecast of 329.7 USD.

Lowest
Price Target
203.01 USD
26% Downside
Average
Price Target
289.08 USD
6% Upside
Highest
Price Target
329.7 USD
21% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CME is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CME Insider Trading
Buy and sell transactions by insiders

CME News

Other Videos
What is the Intrinsic Value of one CME stock?

The intrinsic value of one CME stock under the Base Case scenario is 156.61 USD.

Is CME stock undervalued or overvalued?

Compared to the current market price of 273.55 USD, CME Group Inc is Overvalued by 43%.

Back to Top